Evidence map›Paper›PMID 31105989›Full record

ArticleJournal of drug assessment2019

Prescribing patterns from medical chart abstraction of patients administered lipegfilgrastim: a pilot study in Europe.

Sigal Kaplan, Nicole Lang, Maja Gasparic, Carolyn Rainville, George Haralabopoulos, Emanuele Borroni

Open access · hybridAbstract read
In one paragraph

Article in Journal of drug assessment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Sigal KaplanTeva Pharmaceutical Industries Ltd, Netanya, Israel.ORCID 0000-0002-3352-8480
Nicole LangRatiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV), Ulm, Germany.
Maja GasparicTeva Pharmaceuticals Europe B.V, Amsterdam, The Netherlands.
Carolyn RainvilleTeva Pharmaceutical Industries Ltd, Malvern, PA, USA.
George HaralabopoulosPRA, Mannheim, Germany.
Emanuele BorroniPRA, Mannheim, Germany.
Teva Pharmaceuticals (Germany) · DETeva Pharmaceuticals (Israel) · ILTeva Pharmaceuticals (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug useLipegfilgrastimmedical recordsoff-label usepilot study

Identifiers

PMID31105989
PMCPMC6507864
OpenAlexW2936417414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.